MRE11 and colorectal carcinoma: Interestingly, according to a recent study, deficient MRE11 predicts better prognosis independent of treatment in the long-term disease-free survival (DFS) and overall survival (OS): an inconsistent result compared to our previous findings, although we did not further analyze the prognostic value of MRE11 in CRC (13, 14).